Fig. 2.

Mechanism of nuclear auxin signaling pathway and auxin-dependent regulation of gene expression by MP/ARF5. BDL/IAA12 repressor binds to MP/ARF5 transcription factor at low cellular auxin levels. BDL/IAA12 repressor recruits co-repressors: TPL/TPRs. Additionally, HDA19 maintains chromatin in an unlicensed repressive state. This interaction prevents MP/ARF5 from driving gene transcription (A). At high cellular auxin concentrations, the hormone is perceived by the TIR1–BDL/IAA12 co-receptor complex, followed by ubiquitination and proteasomal degradation of the BDL/IAA12 protein. The chromatin-remodeling complex containing BRM, SYD, histone acetylases, and other TFs physically associates with MP/ARF5. It facilitates chromatin opening and further activation of gene transcription in response to auxin (B). At a suboptimal auxin level, MP/ARF5 may oligomerize with MP/ARF5 or other ARFs, which can shut down expression of the target genes (C). Ac, acetyl group; ASK1, ARABIDOPSIS SKP1 HOMOLOG; Aux/IAA, AUXIN/INDOLE-3-ACETIC ACID; BDL/IAA12, BODENLOS/INDOLE-3-ACETIC ACID 12; BRM/SYD, BRAHMA/SPLAYED; CUL1, CULLIN 1; E2, UBIQUITIN-LIGASE; HAT, HISTONE ACETYLASE; HDA19, HISTONE DEACETYLASE 19; MP/ARF5, MONOPTEROS/AUXIN RESPONSE FACTOR 5; RBX1, RING-BOX 1; TF, transcription factor; TIR1/AFB, TRANSPORT INHIBITOR RESISTANT1/AUXIN SIGNALING F-BOX; TPL/TPR, TOPLESS/TOPLESS RELATED; Ub, ubiquitin. Created with BioRender.com.